Christopher J. Schwartz

420 total citations
32 papers, 234 citations indexed

About

Christopher J. Schwartz is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Christopher J. Schwartz has authored 32 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Cancer Research and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Christopher J. Schwartz's work include Cancer and Skin Lesions (7 papers), Breast Cancer Treatment Studies (7 papers) and Cancer Genomics and Diagnostics (6 papers). Christopher J. Schwartz is often cited by papers focused on Cancer and Skin Lesions (7 papers), Breast Cancer Treatment Studies (7 papers) and Cancer Genomics and Diagnostics (6 papers). Christopher J. Schwartz collaborates with scholars based in United States, Spain and Italy. Christopher J. Schwartz's co-authors include Farbod Darvishian, Leonard D. Kohn, Brian Wallace, Dawn K. Holliday, Kelly D. McCall, Eric Dickerson, Frank Schwartz, Christopher J. Lewis, Walter Raasch and Hannah Y. Wen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Human Pathology.

In The Last Decade

Christopher J. Schwartz

29 papers receiving 232 citations

Peers

Christopher J. Schwartz
Christopher J. Schwartz
Citations per year, relative to Christopher J. Schwartz Christopher J. Schwartz (= 1×) peers Rintaro Ohe

Countries citing papers authored by Christopher J. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Schwartz more than expected).

Fields of papers citing papers by Christopher J. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Schwartz. The network helps show where Christopher J. Schwartz may publish in the future.

Co-authorship network of co-authors of Christopher J. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Schwartz. A scholar is included among the top collaborators of Christopher J. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Schwartz. Christopher J. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Schwartz, Christopher J. & Gregor Krings. (2024). Salivary gland-like tumors of the breast: Histopathologic and genetic features with clinical implications. Seminars in Diagnostic Pathology. 41(6). 272–284.
3.
Bean, Gregory R., Christopher J. Schwartz, Poonam Vohra, et al.. (2024). Targeted DNA Sequencing in Diagnosis of Malignant Phyllodes Tumors With Emphasis on Tumors With Keratin and p63 Expression. Modern Pathology. 37(12). 100593–100593. 6 indexed citations
4.
Esserman, Laura J., Alexa Glencer, Christopher J. Schwartz, et al.. (2024). Abstract PR07: Intratumoral injection of mRNA-2752 and anti-PD-1 results in rapid regression of HER2 positive and or Hormone Receptor Negative DCIS: Phase 1 study results. Cancer Research. 84(3_Supplement_1). PR07–PR07. 1 indexed citations
5.
Schwartz, Christopher J., Antonio Marra, Andrea Gazzo, et al.. (2024). RB1 Genetic Alterations in Estrogen Receptor–Positive Breast Carcinomas: Correlation With Neuroendocrine Differentiation. Modern Pathology. 37(8). 100541–100541. 2 indexed citations
6.
Shamir, Eliah R., Gregory R. Bean, Christopher J. Schwartz, et al.. (2023). Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression. Modern Pathology. 36(12). 100324–100324. 6 indexed citations
7.
Schwartz, Christopher J., Gregory R. Bean, Deepika Sirohi, et al.. (2023). Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior. Modern Pathology. 36(5). 100125–100125. 14 indexed citations
8.
Rothschild, Harriet, W. Fraser Symmans, Christopher J. Schwartz, et al.. (2023). Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes. Breast Cancer Research and Treatment. 202(2). 367–375. 1 indexed citations
9.
Schwartz, Christopher J., et al.. (2023). Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast Cancer Research and Treatment. 204(1). 171–179. 6 indexed citations
10.
Rothschild, Harriet, et al.. (2023). HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series. Breast Cancer Research and Treatment. 199(2). 349–354. 8 indexed citations
11.
Schwartz, Christopher J., Amir Momeni Boroujeni, Alireza Khodadadi‐Jamayran, et al.. (2021). Molecular analysis of encapsulated papillary carcinoma of the breast with and without invasion. Human Pathology. 111. 67–74. 6 indexed citations
12.
Schwartz, Christopher J., Fresia Pareja, Edaise M. da Silva, et al.. (2021). Histologic and genomic features of breast cancers with alterations affecting the SWI/SNF (SMARC) genes. Modern Pathology. 34(10). 1850–1859. 5 indexed citations
13.
Schwartz, Christopher J., et al.. (2021). A Case of Atrial Flutter Masking Acute Pericarditis. Cureus. 13(3). e14168–e14168.
14.
Schwartz, Christopher J., Edi Brogi, Antonio Marra, et al.. (2021). The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features. Modern Pathology. 35(2). 193–201. 28 indexed citations
15.
Hernández, Andrea, Christopher J. Schwartz, Kristen Thomas, et al.. (2019). Pathologic Evaluation of Breast Tissue From Transmasculine Individuals Undergoing Gender-Affirming Chest Masculinization. Archives of Pathology & Laboratory Medicine. 144(7). 888–893. 23 indexed citations
16.
Schwartz, Christopher J., Igor Dolgalev, Varshini Vasudevaraja, et al.. (2019). Revisiting multifocal breast cancer: a clonality study of ductal carcinoma using whole exome sequencing. Human Pathology. 94. 71–77. 1 indexed citations
17.
Schwartz, Christopher J., Igor Dolgalev, Iman Osman, et al.. (2018). Microglandular adenosis is an advanced precursor breast lesion with evidence of molecular progression to matrix-producing metaplastic carcinoma. Human Pathology. 85. 65–71. 12 indexed citations
18.
Schwartz, Christopher J., et al.. (2017). Extrauterine, Extragenital Endometrial Stromal Sarcoma in the Absence of Endometriosis: A Rare Entity. International Journal of Gynecological Pathology. 38(1). 76–77. 3 indexed citations
19.
Schwartz, Christopher J., et al.. (2016). Page kidney: taking a page from history. The American Journal of Emergency Medicine. 35(1). 193.e1–193.e2. 13 indexed citations
20.
McCall, Kelly D., Dawn K. Holliday, Eric Dickerson, et al.. (2010). Phenylmethimazole blocks palmitate-mediated induction of inflammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages. Journal of Endocrinology. 207(3). 343–353. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026